0576-88813233
SR8278 是一種競爭性核血紅素受體 REV-ERB 合成拮抗劑。SR8278 抑制 REV-ERBα 轉(zhuǎn)錄活性,EC50 為 0.47 μM。SR8278 用于調(diào)節(jié)生物體內(nèi)的代謝和研究生物節(jié)律。
[1]. Kojetin , et al. Identification of SR8278, a synthetic antagonist of the nuclear heme receptor REV-ERB. ACS Chem Biol. 2011 Feb 18;6(2):131-4.
[2]. Dong D, et al. A validated ultra-performance liquid chromatography-tandem mass spectrometry method to identify the pharmacokinetics of SR8278 in normal and streptozotocin-induced diabetic rats. J Chromatogr B Analyt Technol Biomed Life Sci. 2016 May 1;1020:142-7.
版權(quán)所有 Copyright(C) 2018-2024 臺(tái)州市科瑞生物技術(shù)有限公司